ZIVO Bioscience Price Target and Analyst Ratings 2023
| EPRSQDelisted Stock | USD 0.0001 0.00 0.00% |
Slightly above 56% of EPIRUS Biopharmaceutica's investor base is looking to short. The analysis of overall sentiment of trading EPIRUS Biopharmaceuticals pink sheet suggests that many investors are alarmed at this time. EPIRUS Biopharmaceutica's investing sentiment overview a quick insight into current market opportunities from investing in EPIRUS Biopharmaceuticals. Many technical investors use EPIRUS Biopharmaceuticals stock news signals to limit their universe of possible portfolio assets and to time the market correctly.
EPIRUS |
The current ZIVO price target is 6.00. Learn why top analysts are making this price prediction for ZIVO Bioscience at MarketBeat.
Read at marketbeat.com
 |
EPIRUS Biopharmaceutica Fundamental Analysis
We analyze EPIRUS Biopharmaceutica's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of EPIRUS Biopharmaceutica using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of EPIRUS Biopharmaceutica based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Total Debt
Total Debt Comparative Analysis
EPIRUS Biopharmaceutica is currently under evaluation in total debt category among its peers. Total Debt refers to the amount of long term interest-bearing liabilities that a company carries on its balance sheet. That may include bonds sold to the public, notes written to banks or capital leases. Typically, debt can help a company magnify its earnings, but the burden of interest and principal payments will eventually prevent the firm from borrow excessively.
EPIRUS Biopharmaceuticals Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with EPIRUS Biopharmaceutica pink sheet to make a market-neutral strategy. Peer analysis of EPIRUS Biopharmaceutica could also be used in its relative valuation, which is a method of valuing EPIRUS Biopharmaceutica by comparing valuation metrics with similar companies.
Peers
EPIRUS Biopharmaceutica Related Equities
| GNTA | Genenta Science | 4.52 | ||||
| ERAS | Erasca | 3.00 | ||||
| MOLN | Molecular Partners | 0.55 | ||||
| EWTX | Edgewise Therapeutics | 0.08 | ||||
| NAMSW | NewAmsterdam Pharma | 0.14 | ||||
| PEPG | PepGen | 1.15 | ||||
| HLVX | Hillevax | 2.34 | ||||
| OPT | Opthea | 3.12 | ||||
| STRO | Sutro Biopharma | 3.47 | ||||
| PHVS | Pharvaris | 3.59 | ||||
| ANTX | AN2 Therapeutics | 3.70 | ||||
| GLTO | Galecto | 4.00 | ||||
| FBRX | Forte Biosciences | 6.40 | ||||
| CNTA | Centessa Pharmaceuticals | 7.04 | ||||
| MLYS | Mineralys Therapeutics, | 13.71 |
Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state. You can also try the Share Portfolio module to track or share privately all of your investments from the convenience of any device.
Other Consideration for investing in EPIRUS Pink Sheet
If you are still planning to invest in EPIRUS Biopharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the EPIRUS Biopharmaceutica's history and understand the potential risks before investing.
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities |